Want to see YDES full AI Analyst Report?
YD Bio Limited (YDES) Stock Statistics & Valuation Metrics
Total Valuation
YD Bio Limited has a market cap or net worth of $420.81M. The enterprise value is $156.71M.
- Market Cap
- $420.81M
- Enterprise Value
- $156.71M
Share Statistics
YD Bio Limited has 70,842,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 70,842,840
- Owned by Insiders
- 76.84%
- Owned by Institutions
- 0.18%
Financial Efficiency
YD Bio Limited’s return on equity (ROE) is 2.91 and return on invested capital (ROIC) is -43.41%.
- Return on Equity (ROE)
- 2.91
- Return on Assets (ROA)
- -0.60
- Return on Invested Capital (ROIC)
- -43.41%
- Return on Capital Employed (ROCE)
- -0.43
- Revenue Per Employee
- 42.63K
- Profits Per Employee
- -593.67K
- Employee Count
- 14
- Asset Turnover
- 0.04
- Inventory Turnover
- 0.34
Valuation Ratios
The current PE Ratio of YD Bio Limited is -49.75. YD Bio Limited’s PEG ratio is 0.10.
- PE Ratio
- -49.75
- PS Ratio
- 708.53
- PB Ratio
- -139.48
- Price to FCF
- -52.62
- Price to Operating Cash Flow
- -60.38
- PEG Ratio
- 0.10
Income Statement
In the last 12 months, YD Bio Limited had revenue of 596.82K and earned -8.31M in profits. Earnings per share was -0.12.
- Revenue
- 596.82K
- Gross Profit
- -42.15K
- Operating Income
- -5.27M
- Pretax Income
- -8.31M
- Net Income
- -8.31M
- EBITDA
- -8.10M
- Earnings Per Share (EPS)
- -0.12
Cash Flow
In the last 12 months, operating cash flow was -1.18M and capital expenditures -3, giving a free cash flow of -1.18M billion.
- Operating Cash Flow
- -1.18M
- Free Cash Flow
- -1.18M
- Free Cash Flow per Share
- -0.12
Dividends & Yields
YD Bio Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.90%
- Earnings Yield
- -2.09%
Stock Price Statistics
- Beta
- 0.28
- 52-Week Price Change
- -47.77%
- 50-Day Moving Average
- 5.10
- 200-Day Moving Average
- 5.40
- Relative Strength Index (RSI)
- 52.56
- Average Volume (3m)
- 304.87K
Important Dates
YD Bio Limited upcoming earnings date is ―, After Close (Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
YD Bio Limited as a current ratio of 5.88, with Debt / Equity ratio of -0.24%
- Current Ratio
- 5.88
- Quick Ratio
- 4.74
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.74
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, YD Bio Limited has paid -1,531 in taxes.
- Income Tax
- -1,531
- Effective Tax Rate
- 0.00
Enterprise Valuation
YD Bio Limited EV to EBITDA ratio is -51.44, with an EV/FCF ratio of -51.87.
- EV to Sales
- 698.48
- EV to EBITDA
- -51.44
- EV to Free Cash Flow
- -51.87
- EV to Operating Cash Flow
- -63.19
Balance Sheet
YD Bio Limited has $6,312.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $6,312.00 billion.
- Cash & Marketable Securities
- $6,312.00
- Total Debt
- $0.00
- Net Cash
- $6,312.00
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$4.71
Margins
Gross margin is -7.06%, with operating margin of -883.31%, and net profit margin of -1392.61%.
- Gross Margin
- -7.06%
- Operating Margin
- -883.31%
- Pretax Margin
- -1392.86%
- Net Profit Margin
- -1392.61%
- EBITDA Margin
- -1357.75%
- EBIT Margin
- -1392.86%
Scores
- Smart Score
- 3
- AI Score
- 44
